does tirzepatide cause sore throat MOUNJARO causa dor na GARGANTA? Otorrino responde Exploring the Potential Side Effects

The trial also assessed clinically meaningful thresholds: over 90% of participants on 4 mg or higher doses lost at least 5% of body weight, and 6083% of them reached 15% or greater reduction, compared with just 27% and 2%, respectively, in the placebo group

25 Jan 2026 | Originally published Ask, share, connect

The priority conditions are I-8 plus the NCD-7, as defined below

Note: 1 in 10 people are non-responders

Embrace Non-Scale Victories : Improved energy, better sleep, and boosted self-confidence are important markers of progress, reminding you of the deeper reasons why weight management is important

This information is reviewed by UK-registered clinicians (GPs or prescribing pharmacists) who assess suitability for treatment